These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34683858)

  • 1. Hyaluronic Acid-Based Nanoparticles for Protein Delivery: Systematic Examination of Microfluidic Production Conditions.
    Chiesa E; Greco A; Riva F; Dorati R; Conti B; Modena T; Genta I
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44-Targeted Carriers: The Role of Molecular Weight of Hyaluronic Acid in the Uptake of Hyaluronic Acid-Based Nanoparticles.
    Chiesa E; Greco A; Riva F; Dorati R; Conti B; Modena T; Genta I
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-Chip Synthesis of Hyaluronic Acid-Based Nanoparticles for Selective Inhibition of CD44+ Human Mesenchymal Stem Cell Proliferation.
    Chiesa E; Riva F; Dorati R; Greco A; Ricci S; Pisani S; Patrini M; Modena T; Conti B; Genta I
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32183027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
    Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
    Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the relationship of hyaluronic acid molecular weight and active targeting efficiency for designing hyaluronic acid-modified nanoparticles.
    Zhong L; Liu Y; Xu L; Li Q; Zhao D; Li Z; Zhang H; Zhang H; Kan Q; Sun J; He Z
    Asian J Pharm Sci; 2019 Sep; 14(5):521-530. PubMed ID: 32104479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
    Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
    Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy.
    Edelman R; Assaraf YG; Levitzky I; Shahar T; Livney YD
    Oncotarget; 2017 Apr; 8(15):24337-24353. PubMed ID: 28212584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
    J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy.
    Zhong L; Xu L; Liu Y; Li Q; Zhao D; Li Z; Zhang H; Zhang H; Kan Q; Wang Y; Sun J; He Z
    Acta Pharm Sin B; 2019 Mar; 9(2):397-409. PubMed ID: 30972285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
    Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
    Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone.
    Sargazi A; Kamali N; Shiri F; Heidari Majd M
    Artif Cells Nanomed Biotechnol; 2018 May; 46(3):500-509. PubMed ID: 28503952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.
    Mizrahy S; Raz SR; Hasgaard M; Liu H; Soffer-Tsur N; Cohen K; Dvash R; Landsman-Milo D; Bremer MG; Moghimi SM; Peer D
    J Control Release; 2011 Dec; 156(2):231-8. PubMed ID: 21745506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
    Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
    Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
    Wang X; Cheng R; Zhong Z
    Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid (HA) stimulates the in vitro expression of CD44 proteins but not HAS1 proteins in normal human epidermal keratinocytes (NHEKs) and is HA molecular weight dependent.
    Gruber JV; Holtz R; Riemer J
    J Cosmet Dermatol; 2022 Mar; 21(3):1193-1198. PubMed ID: 33908161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
    J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
    Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
    Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer.
    Lin T; Yuan A; Zhao X; Lian H; Zhuang J; Chen W; Zhang Q; Liu G; Zhang S; Chen W; Cao W; Zhang C; Wu J; Hu Y; Guo H
    Acta Biomater; 2017 Apr; 53():427-438. PubMed ID: 28213097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tunable CD44-specific cellular retargeting with hyaluronic acid nanoshells.
    Ebbesen MF; Olesen MT; Gjelstrup MC; Pakula MM; Larsen EK; Hansen IM; Hansen PL; Mollenhauer J; Malle BM; Howard KA
    Pharm Res; 2015 Apr; 32(4):1462-74. PubMed ID: 25361867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.